期刊文献+

非酒精性脂肪性肝病胰岛素抵抗程度与全血细胞计数的相关性 被引量:3

Correlation between insulin resistance and complete blood count parameters in nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的探讨伴或不伴2型糖尿病(T2DM)的非酒精性脂肪性肝病(NAFLD)胰岛素抵抗(IR)程度与全血细胞计数各参数的相关性。方法选取糖耐量正常并除外糖尿病史的单纯NAFLD患者102例,T2DM合并NAFLD患者104例,正常对照104例为研究对象,测定空腹血糖(FPG)、空腹胰岛素(FINS)和全血细胞计数,分析胰岛素抵抗指数(HOMA-IR)与全血细胞计数各参数的相关性。结果 T2DM合并NAFLD患者IR及全血细胞计数异常程度较单纯NAFLD患者更重;相关性研究表明男性HOMA-IR与WBC、NEU、LYM、RBC、HGB、HCT呈正相关,女性HOMA-IR与WBC、NEU、LYM、MID、RBC、HGB、HCT呈正相关。结论 NAFLD时白细胞参数和红细胞参数的变化与IR密切相关,T2DM的存在加重了IR对上述血细胞参数的影响。全血细胞计数可以作为反映NAFLD患者IR程度的一种简单实用的检验指标。 Objective To investigate the correlation between insulin resistance(IR) and complete blood count parameters in nonalcoholic fatty liver disease(NAFLD) with or without type 2 diabetes mellitus(T2DM).Methods 102 NAFLD patients without T2DM,104 NAFLD patients with T2DM and 104 healthy controls were selected.Fasting plasma glucose(FPG),fasting insulin(FINS) levels and complete blood count parameters were measured.The degree of insulin resistance was assessed using the homeostasis model assessment(HOMA).Correlation between HOMA-IR and complete blood count parameters were analyzed.Results IR and complete blood count parameters of NAFLD patients with T2DM showed more abnormal than NAFLD patients without T2DM.The correlation studies indicated that HOMA-IR in male was positively related to WBC,NEU,LYM,RBC,HGB and HCT,while in female,it was also positively related to WBC,NEU,LYM,MID,RBC,HGB and HCT.Conclusions Changes of WBC and RBC parameters are closely related to the degree of IR in NAFLD.NAFLD complicated with T2DM aggravates the impact of IR on the parameters of these blood cells.Complete blood count can be used as a simple and practical laboratory test index to reflect the degree of IR in patients with NAFLD.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第16期3371-3373,共3页 Chinese Journal of Gerontology
基金 河北省医学科学研究重点指令性课题(20100001)
关键词 非酒精性脂肪性肝病 2型糖尿病 胰岛素抵抗 全血细胞计数 Nonalcoholic fatty liver disease Type 2 diabetes mellitus Insulin resistance Complete blood count
  • 相关文献

参考文献8

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 2Ellinger VC,Carlini LT,Moreira RO,et al.Relation between insulin re-sistance and hematological parameters in a Brazilian sample(J).Arq Bras Endocrinol Metabol,2006;50(1):114-7.
  • 3Jaskiewicz K,Rzepko R,Sledzinski Z.Fibrogenesis in fatty liver associat-ed with obesity and diabetes mellitus type 2(J).Dig Dis Sci,2008;53(3):785-8.
  • 4Hotamisligil GS.Inflammation and metabolic disorders(J).Nature,2006;444(7121):860-7.
  • 5Lee YJ,Lee HR,Shim JY,et al.Relationship between white blood cell count and nonalcoholic fatty liver disease(J).Dig Liver Dis,2010;42(12):888-94.
  • 6Kim HL,Chung GE,Park IY,et al.Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease(J).Tohoku J Exp Med,2011;223(3):227-33.
  • 7McCarty MF.Hyperinsulinemia may boost both hematocrit and iron ab-sorption by up-regulating activity of hypoxia-inducible factor-1 alpha(J).Med Hypotheses,2003;61(5-6):567-73.
  • 8杨硕,郝维敏,刘敏.血小板参数变化与2型糖尿病患者血管性病变的关系研究[J].蚌埠医学院学报,2010,35(9):945-947. 被引量:4

二级参考文献24

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Craig BT,Katherine A.Size dependent platelet subpopulation relationship of platelet volume to ultranstructure enzymatic activity and function[J].Br J Haematol,1982,50(3):509.
  • 3Endler G,Klimesch A,Suncler-Plassmann H,et al.Mean platelet volume is an independent risk factor for myocardial infardtion but not for coronary disrase[J].Br J Haemasrol,2002,117(2):399-404.
  • 4王吉耀.内科学[M].北京:人民卫生出版社,2003.884.
  • 5Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 6Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 7Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 8Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 9Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 10Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.

共引文献1514

同被引文献32

  • 1Kim N H, Park J, Kim S H, et al. Non-alcoholic fatty liver dis- ease, metabolic syndrome and subclinical cardiovascular changes in the general population [ J ]. Heart,2014,100 (12) :938 - 43.
  • 2Farrell G C, Larter C Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis [ J ]. Hepatology,2006, 43 (2 Suppl 1 ) : S99 -S112.
  • 3Tapan S, Dogru T, Kara M, et al. Circulating levels of interleu- kin-18 in patients with non-alcoholic fatty liver disease [ J]. Scand J Clin Lab Invest,2010,70(6) :399 -403.
  • 4Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity [ J ]. Nature, 2012,482 (7384) : 179 - 85.
  • 5Caballeria L, Pera G, Auladell M A, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain [ J ]. Eur J Gastroenterol Hepatol, 2010,22( 1 ) :24 - 32.
  • 6Lee Y J, Lee H R, Shim J Y, et al. Relationship between white blood cell count and nonalcoholic fatty liver disease [ J ]. Dig Liver Dis,2010,42(12) :888 -94.
  • 7Alkhouri N, Morris-Stiff G, Campbell C, et al. Neutrophil to lym- phocyte ratio: a new marker for predicting steatohepatitis and fi- brosis in patients with nonalcoholic fatty liver disease [ J ]. Liver Int,2012,32(2) : 297 - 302.
  • 8Felipo V, Urios A, Montesinos E, et al. Contribution of hyperam- monemia and inflammatory factors to cognitive impairment in mini- mal hepatic encephalopathy [ J ]. Metab Brain Dis, 2012,27 ( 1 ) : 51 -8.
  • 9杨艳,乔杰,李美芝.白细胞介素18、白细胞介素1β与多囊卵巢综合征发病的相关性研究[J].中国实用妇科与产科杂志,2008,24(1):38-40. 被引量:16
  • 10苏韫,刘永琦,吴建军,张毅,颜春鲁,聂蕾.锁阳对衰老模型大鼠脾淋巴细胞转化能力、脾病理学变化及血清SOD、MDA、NO水平的影响[J].中国老年学杂志,2009,29(8):927-929. 被引量:8

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部